Latest Feature Articles
The cutting edge of cancer research
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Cancer, feature, oncologyWhile immunotherapies continue to be the darling of the industry, new, innovative and sometimes seemingly fantastical research is emerging that …
Working Life: Nicola Redfern, UK General Manager, bluebird bio
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Bluebird Bio, Interview, Working Life, pharmaHow did you find your way into the pharma industry? Was it always an aspiration of yours? My mum worked …
Living with melanoma after surgery
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Cancer, melanoma, patient experience, pharmaDr Elizabeth Walmsley was left lost when she received her melanoma diagnosis. Thankfully, through perseverance and the advice of friends …
Beating the flu
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | flu, influenza, pharma, seqirusOn 14 January, the European Commission issued marketing approval for Flucelvax Tetra, the first cell-based, quadrivalent influenza vaccine. Pharmafocus spoke …
Solving the drug development problem
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | AI, drug discovery, feature, pharma, pistoia allianceExcitement is building for the potential of AI in just about every field, but how can it address pharma’s unique …
Counterfeit drugs – countering the lies
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Counterfeit drugs, IP, counterfeit medicines, falsified medicines, intellectual property, law, legal, patentAs the Falsified Medicines Directive comes into effect in February 2019, Louis Goss fact checks ‘common sense’ claims on counterfeit …
Repurposed drugs: The Supreme Court deals a blow to patentees
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Supreme Court, drug repurposing, feature, patents, pharmaSecond medical use patents protect the discovery that an existing drug is effective to treat a new condition. But, following …
Pushing for progress in mesothelioma
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Cancer, mesothelioma, pharmaMesothelioma.net reviews the wide array of latest advances in treatment and care for patients affected by the challenging cancer as …
Living with Alström syndrome
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Alström syndrome, patient experience, pharma, rare diseaseKay Parkinson lived the tragedy of seeing both of her children born with an ultra-rare condition, and the elusiveness of …
How tech is powering precision treatment
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | AI, Precision Medicine, pharma, techAs the scientific community eschews scattergun approaches and demand rises for higher-quality, targeted care, Matt Fellows explores how technologies such …
Pharma in 2018: Looking back, looking forward
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | 2018, Alligator Bioscience, Eisai, Gilead, Mundipharma, pharma2018 has been a year characterised by uncertainty, but also significant leaps in research, access, and industry deals. With 2019 …
Psychedelic therapy: A new approach to mental health
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | LSD, MDMA, controlled substances, depression, mental health, pharma, psychotherapyIn November 2018, a Phase 2 clinical trial found that 76% of patients who underwent MDMA-assisted psychotherapy no longer had …
Working Life: Kai Gait, Senior Global Digital Director at GlaxoSmithKline
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | EU, GSK, Interview, UK, US, digital, senior global director, technologyKai Gait, Senior Global Digital Director at GlaxoSmithKline, retraces the steps that have led him to where he is today, …
Insider Interview: The diabetes/mental health connection
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Insider Interview, Type 1 diabetes, World Diabetes Day, diabetes, feature, mental health, pharmaMichael Connellan, Head of External Affairs at the type 1 diabetes charity JDRF, discusses the results of a recent survey …
Rising to the challenge of delivering therapeutic discovery for mental disorders
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | NIHRm, Oxford, R&D, feature, investment, mental healthProfessor Matthew Hotopf, Director of NIHR Maudsley Biomedical Research Centre, and Professor John R Geddes, Director of NIHR Oxford Health …
